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The Bel-1 protein of human foamy virus (HFV) is a transactivator acting on the U3 region of the long terminal repeat and
on an internal promoter (IP) immediately upstream of the bel genes. An HFV transgene called Dgpe, containing both
promoters and all bel genes, is expressed in the central nervous system and induces neurodegeneration in mice. To dissect
the role of individual promoters and bel genes on transgene expression and neurotoxicity we generated transgenic mice
with a construct termed pL-bel1, which lacks the IP and the ancillary genes except bel-1. L-bel1 mice transcribed the HFV
transgene in more tissues than Dgpe mice, suggesting that CNS specificity is dictated by cis-acting elements not present
in the pLbel-1 construct. Unlike Dgpe mice, L-bel1 mice did not develop neurodegenerative changes and did not show
induction of nitric oxide synthase expression, although both strains expressed Bel-1 in the brain. Therefore, Bel-1 expression
is not sufficient for neurotoxicity. Our results suggest that Bet, a fusion protein between bel-1 and bel-2 which is highly
expressed in Dgpe but not in L-bel1 mice, is a candidate for neurotoxicity. q 1996 Academic Press, Inc.
INTRODUCTION the consequence of HFV gene expression in a transgenic
model (Bothe et al., 1991; Aguzzi et al., 1992, 1993). We
Human foamy virus (HFV) is a retrovirus encoding the
observed expression of HFV transgenes in the central
structural genes gag, pol, env, and, like HIV and HTLV-
nervous system leading to a severe neurological syn-
I, several ancillary reading frames. These are named bel-
drome in mice harboring a DNA construct termed pHFVAf ,1, bel-2, and bel-3 and are located between env and the
which contains the complete HFV genome with a dis-3*-long terminal repeat (LTR) (Flu¨gel et al., 1987; Muranyi
rupted integrase reading frame, and also in mice con-and Flu¨gel, 1991; Baunach et al., 1993). Foamy viruses
taining the pDgpe construct, in which substantial dele-are endemic to various primate species (Hooks and
tions were introduced in the gag–pol and env genesGibbs, 1975; Hooks and Detrick-Hooks, 1981; Aguzzi,
(Rethwilm et al., 1991; Bothe et al., 1991). These data led1993). The issue of prevalence and pathogenicity of
us to the conclusion that expression of the bel genes offoamy viruses in humans has been the subject of a long
HFV in vivo suffices to elicit a neurological disease. Sincedebate. In contrast to previous reports (Stancek et al.,
the expression of the transgene closely correlates with1975; Muller et al., 1980; Lagaye et al., 1992; Mahnke et
the appearance of structural damage in these mice andal., 1992; Westarp et al., 1992), recent studies of large
inflammatory reactions are virtually absent, the diseasecollectives indicate that foamy viruses do not regularly
is likely to be caused directly by the action of HFV-en-infect human beings and that human-to-human transmis-
coded proteins. Interestingly, the transgene shows a bi-sion of HFV is unlikely to occur (Schweizer et al., 1994,
phasic pattern with broad transient prenatal expression1995; Rethwilm, 1995; Ro¨sener et al., 1996; M. O. Mc-
in various tissues and reexpression, after a latencyClure, personal communication). Expression of HFV ap-
phase, only in the brain (Aguzzi et al., 1992).pears to be controlled by complex mechanisms involving
An important question arising from these observationsthe retroviral bel-1 transactivator gene, a canonical pro-
relates to the contribution of the individual bel genes ofmoter located on the U3 region of the LTR (Rethwilm et
HFV and of the cis regulatory sequences identified soal., 1991; Erlwein and Rethwilm, 1993), an internal Bel-1
far (U3 of the LTR and IP) to the CNS-specific expressiondependent promoter (IP) in the 3*-region of the env gene
pattern of the transgene and to the resulting pathology.(Lo¨chelt et al., 1993a), and most likely yet unidentified
Originally, the Bel-1 protein seemed a reasonable candi-host-derived factors. In previous studies, we have deter-
date for neurotoxicity, since Bel-1 is the transcriptionalmined the tissue tropism of HFV regulatory elements and
transactivator of HFV (Rethwilm et al., 1991; Keller et al.,
1991; Venkatesh et al., 1991), and neurotoxic properties1 To whom correspondence and reprint requests should be ad-
dressed. have been ascribed to the transactivators of other retrovi-
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ruses such as HIV and Visna–Maedi virus (Gourdou et
al., 1990). However, the prediction that Bel-1 would be
neurotoxic could not be fully verified by studying pHFVAf
andDgpe mice (Bothe et al., 1991), since both constructs
contained several additional, also potentially toxic genes.
Therefore, in the present study we have generated
transgenic mice with an additional construct called
pLbel-1, which contains only the bel-1 open reading
frame (ORF) under the direct control of the LTR U3 pro-
moter region. We assumed that transgenic mice express-
ing this construct would allow differentiation between the
effects of bel-1 expression and those elicited by other
bel genes. In order to detect subthreshold neurotoxic
effects which might not be evident upon clinical and
histological examination, we studied CNS expression of
inducible nitric oxide synthase (iNOS), which has often
been associated with viral-induced neurodegenerative
diseases in humans and animal models (Dawson et al.,
FIG. 1. Genomic organization of HFV and the constructs used to1993; Hayman et al., 1993; Bukrinsky et al., 1995).
generate Dgpe and Lbel-1 transgenic mice. (A) The bent arrows mark
the two HFV promoters: the first (5*-LTR) and the IP promoter. The
MATERIALS AND METHODS differently shaded boxes represent the HFV bel genes. The Bet protein
is formed by a splicing which fuses the bel-1 to the bel-2 reading frame.
Genomic organization of HFV and constructs used for In the pDgpe fragment used for generation of transgenic mice, the
generating the Dgpe and Lbel-1 transgenic mice NcoI deletion preserves the first 383 codons of gag, and the HpaI/PvuII
deletion preserves the first 197 codons of env. Instead, the bel genes
The Dgpe construct was described previously (Reth- are not affected. The pDgpeH fragments contain in addition to pDgpe
a 94-bp HindIII (H) deletion in bel-2 and bel-3. In the pLbel-1 constructwilm et al., 1991; Bothe et al., 1991). It consists of the
all the HFV genes were deleted except bel-1 standing under the tran-HFV genome in a noninfectious form, due to deletions
scriptional control of the U3 region of the 5*-LTR. In this construct, theof 2.3 kb in gag–pol and 1.6 kb in env (Fig. 1A). The
Bet ORF has been interrupted. Restriction sites are abbreviated as
transcripts generated by this construct allow only for ex- follows: N, NcoI; Hp, HpaI; B, BbvI; S, SspI; P, PvuII; H, HindIII. The
pression of truncated amino-terminal fragments of gag positions in the HFV genome are indicated below the restriction en-
zymes. (B) Detailed structure of the Lbel-1 transgene and expectedand env, while no pol gene products can be expressed.
size of the transcripts allowing translation of Bel-1 and truncated BetThe bel genes are not affected by these deletions and
(not drawn to scale). The SspI (S) probe was used for Northern blotcan be normally expressed. Transcription of the bel
analysis (Fig. 2). SA, splice acceptor; SD, splice donor. Truncated se-
genes is under the control of the HFV LTR and the re- quences are in parentheses.
cently identified IP (Lo¨chelt et al., 1994).
The Lbel-1 construct (Fig. 1B) was made by inserting
the HFV bel-1 gene as a 1048-bp SspI fragment excised in a Mendelian fashion. From these two mice, the
from pHSRV1 (Rethwilm et al., 1991) into the BglII site of transgenic lines 621 and 656 were established.
the HFV expression vector pL1 (Schmidt and Rethwilm,
1995) by blunt-end ligation. Expression of the Bel-1 pro- Histological examinations
tein and a truncated version of the Bet protein (amino
Histopathological analysis of Lbel-1 transgenic miceacids 1–217) is directed by the HFV LTR U3 region
involved the use of conventional histology and immuno-(0777//4).
histochemistry with antisera to Bel-1/Bet, following pro-
cedures previously optimized (Aguzzi et al., 1990, 1991,Dgpe and Lbel-1 transgenic mice
1993). For paraffin histology, whole mouse brains were
fixed for at least 24 hr in 4% paraformaldehyde in phos-The Dgpe transgenic mice have been described pre-
viously in detail (Bothe et al., 1991; Aguzzi et al., 1992, phate-buffered saline (PBS). Coronal slices of approxi-
mately 2 mm thickness were dehydrated through graded1993). Standard microinjection procedures were used for
the generation of Lbel-1 transgenic mice (Hogan et al., alcohols and embedded in paraffin. Sections of 4 mm
nominal thickness were mounted on TESPA-coated glass1986). DNA analysis was performed by Southern blotting
and PCR as described (Bothe et al., 1991) on DNA from slides (Sigma) and stained with hematoxylin and eosin
(H&E) and Luxol fast blue–Nissl. On selected sections,tail biopsies taken at the time of weaning. By these
means, we identified several pups containing pLbel-1 Luxol fast blue was combined with H&E. For frozen sec-
tions, mouse brains were removed from the skull, imme-DNA, two of which passed the transgene to their progeny
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diately snap frozen in embedding medium, and stored at membrane with 0.5% methylene blue in 0.5 M sodium
acetate (pH 5.4). Prehybridization was performed in0707. Sections (12 mm) were cut at 0207, mounted on
silanized glass slides, and stored at 0207 until use. Church’s buffer (0.3 M disodium hydrogen phosphate,
0.15% orthophosphoric acid, 7% SDS, 1 mM EDTA, pHImmunohistochemistry for glial fibrillary acidic protein
(GFAP, polyclonal, 1:300, Dako), synaptophysin (poly- 7.2) at 657 for 1 hr. Probes were labeled with [32P]dCTP
(Feinberg and Vogelstein, 1984) and hybridized overnightclonal, 1:40, Dako), S100 (polyclonal, 1:300, Dako), and
neurofilament protein (70- and 200-kDa subunits; mouse in Church’s buffer at 657. The membrane was washed
twice for 20 min in 0.51 SSC and 0.1% SDS at 627. Cohy-monoclonal, 1:20, Bio-Science) was performed on all par-
affin-embedded and frozen sections. Biotinylated sec- bridization was performed with two probes: the SspI frag-
ment spanning the entire bel-1 ORF of HFV (nucleotidesondary antibodies (goat anti-rabbit; rabbit anti-mouse)
were used at a dilution 1:200. Visualization was achieved 9339 to 10386) and a cDNA fragment derived from the
housekeeping gene glyceraldehyde 3-phosphate dehy-using biotin/avidin-peroxidase (Dako) and diaminobenzi-
dine as a chromogen following protocols suggested by drogenase (GAPDH). The GAPDH signal did not interfere
with the transgene-specific transcripts. Using a Phos-the manufacturer.
phorImager, the transgene expression was quantified
RNA expression analysis relative to the expression of GAPDH (Fig. 3). As a positive
control, RNA from BHK-21 cells transfected with the HFV
To obtain positive control RNA and protein extracts,
infectious molecular clone was used.
baby hamster kidney (BHK-21) cells were transfected
with an infectious molecular clone of HFV or, alterna-
Reverse transcription of transgenic RNA andtively, with the plasmids pLbel-1 and pDgpe using the
amplification of cDNA by PCRDOTAP transfection reagent (Boehringer-Mannheim).
Cells were trypsinized and reseeded at 50% confluence
mRNA (1.5 mg) from Dgpe, Lbel-1, and wild-type
3 hr before RNA isolation in order to ensure exponential
mouse brains were digested with DNase I in a total vol-
growth. Transgenic and wild-type mice were sacrificed,
ume of 100 ml containing 10 mM Tris–HCl, pH 8.0, 10
and the organs were isolated and immediately frozen in
mM MgCl2 , 100 U/ml RNase-free DNase I (Boehringer-liquid nitrogen. After homogenization of the tissues or
Mannheim), 1 U/ml RNase inhibitor (RNasin, Promega).
cells total RNA was isolated by the acid guanidinium
The reaction was allowed to proceed for 30 min at 377.
thiocyanate–phenol–chloroform extraction method
After phenol extraction and ethanol precipitation, reverse
(Chomczynski and Sacchi, 1987). The amount of total
transcription and PCR amplification were performed with
RNA was quantitated by measuring the optical density
the GeneAmp RNA PCR kit from Perkin–Elmer. For cDNA
at 260 nm, and all RNA extracts were adjusted to a con-
synthesis, 30 ng of mRNA with random hexamer primers
centration of 1 mg/ml. For RT–PCR and primer extension
(2.5 mM) were used in a total volume of 20 ml containing
experiments, mRNA was isolated directly from tissues or
2.5 U/ml murine leukemia virus reverse transcriptase, 5
from cell homogenates using the mRNA purification kit
mM MgCl2 , 11 PCR buffer II (Perkin–Elmer), 1 mM dNTP,DYNABEADS.
and 1 U/ml RNase inhibitor. The temperature profile of
the reverse transcription was 15 min at 427, denaturationNorthern blot hybridization
for 5 min at 997, and finally cooling for 5 min at 57 in a
Perkin–Elmer Thermal Cycler 480. PCR amplification ofTen-microgram samples of RNA were diluted in load-
ing buffer composed of 6% formaldehyde, 10 mM MOPS cDNA was then carried out, using primers for iNOS
(Sands et al., 1994) (sense, 5*-TTC-CGA-AGT-TTC-TGG-(morpholinepropanesulfonic acid, pH 7.0), 62.5% for-
mamide, 0.001% (w/v) bromphenol blue. After heating to CAG-CA-3*; antisense, 5*-ATA-GGA-AAA-GAC-TGC-
ACC-GAA-GAT-3*) and b-actin (Sands et al., 1994)707 for 5 min and chilling on ice, the samples were elec-
trophoresed through a 1% agarose gel (20 mM MOPS – (sense, 5*-CTC-TTT-GAT-GTC-ACG-CAC-GAT-TTC-3*;
antisense, 5*-GTG-GGC-CGC-TCT-AGG-CAC-CAA-3*).5 mM sodium acetate–1 mM EDTA–6% formaldehyde)
at 100 V in 20 mM MOPS, pH 7.0, 5 mM sodium acetate, The PCR reaction was performed in a total volume of
100 ml containing 2 mM MgCl2 , 11 PCR buffer II (Perkin–1 mM EDTA, and 6% formaldehyde. The gel was washed
in 201 SSC (3 M NaCl, 0.3 M Na3 citrate) before transfer- Elmer), 2.5 U AmpliTaq DNA Polymerase (Perkin–Elmer),
and 0.5 mM of each primer. The following cycling profilering the RNA in 201 SSC onto a nylon membrane (Hy-
bond-N/; Amersham) with the Stratagene PosiBlot pres- was used: 120 sec, 957, followed by 35 cycles (60 sec,
957; 60 sec, 607; and 90 sec, 727); and 7 min, 727. Totalsure blotting system. The membrane was then washed
a few minutes in 201 SSC and dried for 15 min at 65 7. RNA from the liver of a wild-type mouse was run under
the same conditions as control. PCR products were ana-The RNA was then fixed to the membrane by UV cross-
linking (UV-Stratalinker 1800, Stratagene). Transfer effi- lyzed by agarose gel electrophoresis and stained with
ethidium bromide.ciency and RNA quality were controlled by staining the
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Protein extraction and Western blot analysis
For detection of HFV proteins in transgenic mice by West-
ern blot, pDgpe and pLbel-1 transfected BHK-21 cells and
brains from Dgpe and Lbel-1 transgenic mice were lysed
in detergent buffer (0.5% Nonidet P40, 0.5% sodium deoxy-
cholate in PBS) and homogenized for a few seconds with
an electric tissue homogenizer. After centrifugation at 2000
rpm for 10 min at room temperature, the supernatant (10%
homogenate) was quantified using a biuret-bicinchoninic
acid (BCA) reaction (BCA protein assay reagent, Pierce)
and the protein samples were diluted to 1 mg/ml. Protein
samples (20 mg) were then separated by SDS–PAGE and
blotted onto nitrocellulose membranes (Hybond-ECL, Am- FIG. 2. Northern cohybridization analysis of two heterozygous Lbel-
1 transgenic mice at the age of 7 and 50 weeks with the SspI (S) probeersham). To verify transfer efficiency, the membranes were
(Fig. 1B) spanning the entire bel-1 ORF and a GAPDH housekeepingreversibly stained with Ponceau S solution (101 solution:
probe. Ten micrograms of total RNA from the spleen, liver, thymus,
26 mM Ponceau S, 1.8 M trichloroacetic acid, 1.2 M sulfo- heart, lungs, gonads, intestine, kidneys, muscles, brain, thyroid, BHK-
salicylic acid). The membranes were then blocked over- 21 cells transfected with the HFV infectious molecular clone (/), and
night in PBS, pH 7.5, containing 5% bovine serum albumin, the liver of a wild-type mouse (0) was loaded. For BHK-21 cells, the
2.1- to 4-kb RNA corresponds to the singly and multiply spliced specieswashed in PBS containing 0.5% Tween-20, and reacted
of bel-1 and bet described previously (Muranyi and Flu¨gel, 1991). Forwith the antibodies in PBS/BSA (5%) for 1 hr at 377. Antibod-
Lbel-1 mice, the 1.8- to 2.1-kb RNA corresponds to the singly spliced
ies were diluted as follows: 1:500 for the rabbit anti-Bel-1 truncated bet and bel-1 species, respectively. The time of exposure
and rabbit anti-Bel-2 serum (Aguzzi et al., 1993; Baunach was 16 hr. Expression of the transgene is detectable in several organs
et al., 1993) and 1:2500 for the peroxidase-conjugated sec- and is particularly high in the liver and gonads of animals at various
ages.ondary antibody (Dako). After washing, the immunostain
was developed using a chemiluminescence detection sys-
tem (Amersham) and Kodak X-ray films.
wild-type C57Bl/6 x C3H F1 mice. The transgene was
propagated in a Mendelian fashion. Mice expressing theChloramphenicol acetyltransferase (CAT) assay
Lbel-l and the Dgpe transgene were observed clinically
The HFV effector plasmids pHFVAf , pDgpe, and and analyzed by means of conventional histology and
pDgpeH were described previously (Rethwilm et al., immunohistochemical techniques for the presence of a
1991). pDgpeStu contains a mutation in bel-1 (Baunach neurodegenerative phenotype and for systemic disease
et al., 1993) which does not affect the bel-2 ORF. The manifestations. The histopathological changes in Dgpe
construction of pLbel-1 is explained above. The effector mice have been described previously (Bothe et al., 1991):
plasmids and p5*cat (0777//4) (Rethwilm et al., 1991) starting at the age of 7 weeks, the brains of Dgpe
indicator plasmid were transfected into 5 1 105 BHK-21 transgenic mice showed selective nerve cell degenera-
cells (Graham and van der Eb, 1973). Herring sperm was tion with tissue atrophy and reactive astrogliosis in the
added to the transfection mix to adjust the DNA concen- cortex and hippocampus. No primary inflammatory reac-
tration to 40 mg/ml. After 36 hr, cells were harvested tions were seen. In contrast, the Lbel-1 transgenic mice
and CAT assays were performed as described previously remained clinically healthy (observation time, 18
(Erlwein and Rethwilm, 1993) with 50 mg of protein from months) and did not show any neurodegenerative
each batch of transfected cells. Quantification of the ace- changes in the brain and spinal cord upon histological
tylated and nonacetylated chloramphenicol on the chro- examination. GFAP immunohistochemistry and expres-
matography plates was performed using a Phosphor- sion analysis for the markers detailed under Materials
Imager device (Molecular Dynamics). and Methods section did not reveal any abnormalities.
RESULTS Northern blot analysis of Lbel-1 transgenic RNAs
Phenotypic analysis of L-bel1 transgenic mice
Total RNA from the spleen, liver, heart, lung, gonads,
intestine, muscle, brain, thyroid, thymus, and kidney fromFigure 1 shows the vector pLbel-1 used for microinjec-
tion. Six mice were pregnant and 2 of 35 offspring were Lbel-1 mice and from BHK-21 cells transfected with the
HFV infectious molecular clone (positive control in Fig.transgenic. In both founder animals, the number of inte-
grated copies was estimated to be 3 per haploid genome 2) was analyzed by Northern blot hybridization (Fig. 2).
Hybridization of the RNA from BHK cells with the SspIby slot blot analysis and PhosphorImager quantification
(data not shown). The offspring were then crossed with DNA fragment of HFV detected bands in the range of 2.1
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cific protein in the brain of Dgpe mice. A weak band
of 36 kDa became visible in all lysates with the Bel-1
antiserum. Since no protein of 36 kDa was stained with
the Bel-2 antibody, we conclude that this band repre-
sented authentic Bel-1 protein.
Transactivation of the HFV LTR by pLbel-1 and
pDgpe
The constructs used for the generation of Dgpe and
Lbel-1 transgenic mice were tested for their ability to en-
hance expression of a reporter gene directed by the U3FIG. 3. Comparison of transgenic expression in different organs of
Lbel-1 transgenic mice. The specific signals of the radioactive SspI region of the HFV LTR. The U3 region was shown to be
fragment of the HFV bel region and of glyceraldehyde 3-phosphate sufficient to confirm transcriptional responsiveness to the
dehydrogenase (GAPDH) probes were quantified with a PhosphorIm- HFV transactivator Bel-1 (Rethwilm et al., 1991). Effector
ager. The relative expression of the transgene was calculated (SspI
and indicator plasmids were transfected into BHK-21 cellssignal/GAPDH signal) and visualized by the differently shaded columns
and CAT assays were performed. A representative exampleon the Y-axis. Spleen, liver, thymus, heart, lungs, gonads, intestine,
kidneys, muscles, brain, and thyroid of three homozygous Lbel-1 and quantitative analysis is shown in Fig. 5. Induction was
transgenic mice at the age of 7, 20, and 32 weeks were analyzed (X- measured in relation to pDgpeStu , a negative control in
axis). In contrast to the Dgpe transgenics, expression of the transgene which a critical domain of the bel-1 transactivator region
was not restricted to the brain. The Dgpe and L-bel1 transgenes are
was deleted (lane 4). Therefore, the activity of the indicatordepicted in Fig. 1.
plasmid cotransfected with pDgpeStu indicates the basal
transcriptional level of the HFV U3 LTR in the absence ofto 4 kb, corresponding to singly and multiply spliced
biologically active Bel-1. The results demonstrate that thespecies of bel-1 and bet (Muranyi and Flu¨gel, 1991). Het-
pLbel-1 construct is capable of transactivating U3 LTR-di-erozygous Lbel-1 mice were analyzed from 7 to 50 weeks
rected transcription (lane 5). However, the extent of trans-of age. The animals were asymptomatic and no neurode-
activation was weaker than that in the case of the pDgpegeneration could be found histologically. As expected
construct (lane 2).from the Lbel-1 construct which lacked all the structural
and regulatory genes except the bel-1 ORF, Northern blot
iNOS expression is upregulated in brains of Dgpeanalysis showed only one broad band in the range of
transgenic miceabout 1.8 to 2.1 kb, corresponding to the genomic bel-1
and singly spliced bet species (Fig. 1B). The comparison Using the PCR primers described above, the length of
of the relative expression in different organs from three RT–PCR products for iNOS is 500 bp and for b-actin, 549
different heterozygous Lbel-1 transgenic mice is shown bp (Sands et al., 1994). Figure 6 illustrates the results of
in Fig 3. Expression in the brain was detectable, although PCR products obtained with these primers. In contrast to
at somewhat lower levels than in Dgpe mice. In contrast Dgpe, no iNOS message was detectable in brains of Lbel-
to the Dgpe transgenics, expression was not restricted 1 and wild-type mice. All the amplifications were specific,
to the CNS. Particularly strong expression was found in reproducible, and not resulting from small amounts of geno-
the liver and the gonads. mic DNA remaining in the RNA preparations, since direct
PCR amplification on total RNA preparations did not result
Immunodetection of HFV-specific proteins in Dgpe in the detection of any bands (data not shown).
and Lbel-1 transgenic mice
DISCUSSIONProtein was isolated from the CNS of Lbel-1 andDgpe
transgenic mice and from cells transfected with the plas- Transcriptional control of tissue specificity in HFV
mids used for microinjection (pLbel-1, pDgpe). Lysates transgenic mice
were separated on protein gels, blotted on nitrocellulose
membranes, and probed with Bel-1 and Bel-2 immune Adult mice transgenic for a HFV proviral clone or deriv-
atives thereof (pDgpe) harboring all known cis (LTR andsera. With Bel-1 antiserum, a very prominent band of 60
kDa became visible in lysates from pDgpe transfected IP)- and trans-regulatory elements (bel genes) show a
strict tissue-specific expression pattern (Bothe et al.,cells and Dgpe transgenic animals. Since a protein with
an identical molecular weight was also stained with the 1991; Aguzzi et al., 1993). In order to better define cis-
regulatory elements which control this tissue specificityBel-2 antiserum, these data are in agreement with the
previous finding of a Bel-1/Bel-2 fusion protein called Bet we established transgenic mouse lines for a construct
in which the bel-1 gene was placed under control of the(Muranyi and Flu¨gel, 1991; Lo¨chelt et al., 1991; Baunach
et al., 1993). Therefore, Bet is the predominant HFV-spe- LTR U3 region (pLbel-1). As shown by in vitro experi-
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thought to be due to the transactivator Bel-1. Although
its precise mechanism of action is not known, Bel-1 has
not been shown to bind directly to DNA and is thought to
act via complex formation with additional, yet unidentified
host transcription factors (Erlwein and Rethwilm, 1993;
Lee et al., 1993; Rethwilm, 1995). It is therefore conceiv-
able that Bel-1, besides transactivating viral gene expres-
sion, also deregulates the expression of important cellu-
lar genes, leading to cytotoxic consequences. Similar
phenomena have been demonstrated for the transactiva-
tors of HTLV-1 (Nerenberg et al., 1987) and of Visna–FIG. 4. Western blot analysis with Bel-1 (A) and Bel-2 (B) antisera in
brain lysates from Dgpe and Lbel-1 transgenic mice, in wild-type mice, Maedivirus (Gourdou et al., 1990). If this mechanism also
and in lysates from BHK-21 cells transfected with the plasmids pDgpe applies to Bel-1, it may lead to interference with important
and pLbel-1 that were used to generate the Dgpe and Lbel-1 cellular functions.transgenics. (A) Bel-1 antiserum detected the 36K Bel-1 protein in all
The Lbel-1 transgenic mice were also generated tolysates except the wild-type mouse and the 60K Bet protein in Dgpe
investigate whether the HFV transactivator Bel-1 is suffi-brain lysates and lysates from pDgpe transfected BHK-21 cells. (B)
Lysates were reacted with antiserum directed against the carboxy- cient to induce neurodegeneration in HFV transgenic
terminal Bet protein (Fig. 1A). The 60K Bet protein was detected in mice. However, in contrast to all analyzed Dgpe
lanes with Dgpe and pDgpe. MW: molecular weights (in kDa) are transgenic families, L-bel1 mice showed no neurodegen-indicated to the left.
eration although Bel-1 protein was detectable in the brain
(Fig. 4) and functional transcriptional activity of the pLbel-ments with a suitable reporter gene construct pLbel-1
1 encoded protein was demonstrated in a CAT assaywas able to express functional Bel-1 protein. The analy-
(Fig. 5). The striking phenotypic difference betweensis of Lbel-1 transgenic mice revealed a striking differ-
Dgpe and L-bel1 transgenic mice is not likely to be dueence in tissue distribution of transgene expression com-
pared to Dgpe mice. While a large number of indepen-
dent strains of Dgpe transgenic mice always displayed
an essentially identical pattern of CNS-restricted expres-
sion, a broad range of tissues expressed HFV genes
in L-bel1 transgenic mice (Fig. 3). This result strongly
suggests that brain-specific expression is controlled by
an element(s) present in the Dgpe construct, but which
is not contained in the Lbel-1 transgene. This element,
which is likely to function as a silencer for non-CNS
tissues, may reside within the IP, the R-U5 region of the
LTR, or as yet unidentified elements in the genome. It is
unlikely (though not formally excluded) that proteins other
than Bel-1 influence the tissue specificity of the
transgene in trans, since a trans activity has been as-
cribed solely to Bel-1 in various experiments (Rethwilm
et al., 1991; Keller et al., 1991; Baunach et al., 1993).
On the other hand, we cannot exclude that the unique
FIG. 5. Transactivational activity of the constructs used for generatingexpression pattern of Dgpe mice results from the inter-
the Dgpe and Lbel-1 transgenic mice in comparison to other deletion
play of positive and negative elements present in the IP mutants of a infectious HFV molecular clone. Indicator and effector
and in the LTR promoter. Indeed, cis interactions be- plasmids were cotransfected into BHK-21 cells. CAT activity in the
lysates of transfected cells was determined, and the fold activation bytween the IP and the LTR promoter were demonstrated
a given effector plasmid was calculated relative to the value obtainedin a previous study (Lo¨chelt et al., 1993b). The analysis
by cotransfecting pDgpeStu (lane 4), lacking the transactivator Bel-1,of transgenic mice with further mutations of the promoter
as a mean from three independent experiments. The deletion mutants
regions should help narrowing the location of the rele- (deleted gene and lane in parentheses) pHFVAF , (integrase in pol, lane
vant control elements. 1), pDgpe (gag–pol and env, lane 2), pDgpeH (bet, lane 3), and
pDgpeStu (bel-1, lane 4) of an infectious molecular clone were used in
Expression of the transactivator Bel-1 is not sufficient a previous independent study (Rethwilm et al., 1991) to map the HFV
transactivator function to one of the HFV genes. In the indicator plasmidfor induction of neurodegeneration in HFV transgenic
p5*cat (0777//4) the U3 and four bases of R from the HFV 5*-LTRmice
were located in front of the indicator gene (Erlwein and Rethwilm, 1993).
Originally, the neurodegeneration described in the Conclusively, pLbel-1 (lane 5) shows transactivational activity although
only 39% of the pDgpe activity.HFV Dgpe transgenic mice (Bothe et al., 1991) was
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provides further evidence that no pathological processes
are taking place in their CNS.
The fusion protein Bet is a candidate for the
development of neurodegeneration in HFV transgenic
FIG. 6. Inducible nitric oxide (iNOS) transcription in the CNS of HFV mice
transgenic mice. mRNA extracted from brain samples of Dgpe and
Although the HFV accessory protein Bet is the mostLbel-1 transgenic and from wild-type (wt) mice were reverse tran-
scribed and analyzed by PCR with primers (Sands et al., 1994) specific abundant retroviral product in HFV-infected cells, its func-
for iNOS and b-actin sequences. The RT–PCR products were electro- tion is still completely obscure (Baunach et al., 1993;
phoresed through 1% agarose and visualized with ethidium bromide. Hahn et al., 1994; Rethwilm, 1995). Bet does not have
iNOS RT–PCR product was 500 bp; b-actin product was 549 bp. Dgpe
transactivating properties, and disruption of the Bet read-transgenic mice develop a severe neurodegenerative disease with a
ing frame does not impair replication of transfected mo-neurological syndrome consisting of ataxia, spastic tetraparesis, and
blindness. In these mice, iNOS transcription was detected but absent lecular clones of HFV (Baunach et al., 1993; Yu and Linial,
in Lbel-1 transgenics, free from histological and clinical signs of neuro- 1993). Several lines of evidence presented in this work
degeneration. No iNOS expression in wild-type mice (wt) either. imply that Bet, rather than Bel-1, is causally involved in
the neurodegenerative disease of Dgpe transgenic ani-
simply to the twofold increased transactivational activity mals. Abundant amounts of Bet are detectable by West-
of the pDgpe construct (Fig. 5), since DgpeH , an addi- ern blot analysis in the brains ofDgpe transgenics show-
tional transgenic construct (Fig. 1A) showing comparable ing a neurodegenerative disease (Fig. 4), while Lbel-1
expression levels and transactivational activity as Dgpe and DgpeH transgenic mice, in which the bet reading
in in vitro experiments (Fig. 5) and brain-specific expres- frame is disrupted (Fig. 1A), do not develop a neurode-
sion in transgenic animals, also did not produce a neuro- generative disease despite expression of Bel-1. Further,
degenerative phenotype in transgenic mice. accumulation of immunoreactivity with an antiserum to
For the above reasons, the finding that sustained long- a recombinant protein encompassing the whole bel-1
term expression of the HFV transactivator Bel-1 did not reading frame in the cytoplasm and processes of neu-
induce neurodegeneration or other symptoms in L-bel1 rons of Dgpe transgenic mice immediately precede the
transgenic mice was very surprising. To substantiate this appearance of structural damage (Aguzzi et al., 1993).
unexpected result and to rule out subthreshold tissue While the latter antibody does not distinguish between
CNS damage which may remain undetected upon histo- Bel-1 and Bet, Western blot analysis (Fig. 4) indicates
pathological analysis, we analyzed the expression of that Bet contributes to most of the immunohistochemical
iNOS in the brain of L-bel1 and Dgpe transgenic mice. signal. This is in agreement with the cytoplasmic local-
Several studies have shown that nitric oxide (NO) is in- ization, which would be surprising for Bel-1 since its
volved in neurotoxicity associated with viral infection of trans-activating function demands nuclear localization
human and animal brains (Campbell et al., 1994; Dawson (Venkatesh et al., 1993).
et al., 1993; Hayman et al., 1993; Koprowski et al., 1993). Given the current interest in the development of HFV-
NO-mediated neurotoxicity seems to be an important based vector systems for gene transfer and gene ther-
step in HIV-induced neurological complications (Bukrin- apy, it is mandatory to identify the retroviral elements
sky et al., 1995). Three different NOS isoforms have been important for high-level expression, and it would be very
identified which fall into two distinct types, constitutive desirable to separate them from those which may be
(cNOS) and inducible (iNOS). Under physiologic condi- toxic to target cells. The present study suggests that Bel-
tions cNOS is expressed in neurons and endothelial 1, one of the crucial genes for efficient expression of HFV,
cells, whereas iNOS is undetectable. Astrocytes, microg- may not be sufficient for induction of neurodegeneration.
lia, and even neurons (Minc and Schwartz, 1994) can be Instead, the main neurotoxic determinant may be Bet,
induced by cytokines to express iNOS. which appears to be dispensible for efficient expression
Reactive astrocytes and activated microglia are consis- of HFV in vitro (Baunach et al., 1993; Yu and Linial, 1993).
tently found in proximity of areas of neurodegeneration in If confirmed in other biological systems, these results
Dgpe transgenic mice (Bothe et al., 1991), and indeed we may contribute to the development of a safe, Bet-deleted
could show induction of iNOS mRNA transcription in the HFV-based vector (Schmidt and Rethwilm, 1995) with
brain of Dgpe transgenic animals, but never in L-bel1 and minimized neurotoxic potential.
in wild-type mice. These results suggest that the pathogen-
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